929619-01-2

Upstream product

• 63521-92-6 4-pentenoic anhydride 
• 69567-11-9 2,3,4,6-tetra-O-benzyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 78136-16-0 2,3,4,6-tetra-O-benzyl-D-glucitol 
• 214041-43-7 (2R,3R,4S)-2,3,4,6-tetrakis(benzyloxy)-5-oxohexanal 
• 4291-69-4 2,3,4,6-Tetra-O-benzyl-D-glucopyranose 

Downstream Products

• 929619-02-3 6-O-acetyl-2,3,4-tri-O-benzyl-N-pent-4'-enoyl-1-deoxynojirimycin 
• 929619-03-4 2,3,4-tri-O-benzyl-N-pent-4'-enoyl-1-deoxynojirimycin 
• 929619-05-6 2,3,4-tri-O-benzyl-6-O-[1-(adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin 
• 929619-06-7 2,3,4-tri-O-benzyl-N-butyl-6-O-[1-(adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin 
• 929619-04-5 2,3,4-tri-O-benzyl-N-pent-4'-enoyl-6-O-[1-(adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin 

Relevant academic research and scientific papers

Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man

(Chemical Equation Presented) In this article, we present a straightforward synthesis of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives. The used synthetic routes are flexible and can be used to create a wide variety of lipophilic mo